Proceedings of the National Academy of Sciences · 1998 · 546 citations · 36 references
MedicineBiochemistryPharmacologyCell SignalingHemostasisSignal TransductionG Protein-coupled Receptor SignalingMembrane ReceptorsPlatelet ActivationPlatelet AggregationPlatelet FunctionPlatelet PhysiologyAdenosine Diphosphate-induced Platelet AggregationAdenylate Cyclase SignalingAdenylyl Cyclase SignalingG-protein-coupled ReceptorsPlatelet Aggregation InhibitionPlatelet Responses To AgonistsReceptorsSerotonin Receptors
ADP is a key platelet agonist that induces shape change and aggregation for hemostasis, and platelets express two distinct G protein‑coupled ADP receptors—P2Y1 linked to phospholipase C and P2T AC linked to adenylyl cyclase inhibition. The study aimed to show that simultaneous signaling through both P2T AC (Gi) and P2Y1 (Gq) receptors is required for ADP‑induced platelet aggregation. Using selective antagonists and receptor co‑activation experiments, the authors demonstrated that platelet aggregation depends on concurrent Gi and Gq signaling, which can be achieved by activating either the P2T AC/P2Y1 pair or other Gi/Gq receptor combinations. Blocking either Gi‑ or Gq‑coupled receptor alone abolishes ADP‑induced aggregation, while Gi signaling can be substituted by α2A‑adrenergic activation, Gq signaling by serotonin receptor stimulation, and the process can be replicated by co‑activating any Gi/Gq receptor pair.
ADP is an important platelet agonist causing shape change and aggregation required for physiological hemostasis. We recently demonstrated the existence of two distinct G protein-coupled ADP receptors on platelets, one coupled to phospholipase C, P2Y1, and the other to inhibition of adenylyl cyclase, P2T AC . In this study, using specific antagonists for these two receptors, we demonstrated that concomitant intracellular signaling from both the P2T AC and P2Y1 receptors is essential for ADP-induced platelet aggregation. Inhibition of signaling through either receptor, by specific antagonists, is sufficient to block ADP-induced platelet aggregation. Furthermore, signaling through the P2T AC receptor could be replaced by activation of α 2A -adrenergic receptors. On the other hand, activation of serotonin receptors supplements signaling through the P2Y1 receptor. Moreover, this mechanism of ADP-induced platelet aggregation could be mimicked by coactivation of two non-ADP receptors coupled to G i and G q , neither of which can cause platelet aggregation by itself. We propose that platelet aggregation results from concomitant signaling from both the G i and G q , a mechanism by which G protein-coupled receptors elicit a physiological response.
36
Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood Platelets
Anne Gaarder, Jon Jonsen, S. Laland et al. · Nature · 1961 · 788 citations
Medicine, Hematology, Physiology +16
Defective platelet activation in Gαq-deficient mice
Stefan Offermanns, Christopher F. Toombs, Yi-Hui Hu et al. · Nature · 1997 · 562 citations
Medicine, Genetics, Hematology +12
Molecular Basis for ADP-induced Platelet Activation
James L. Daniel, Carol Dangelmaier, Jianguo Jin et al. · Journal of Biological Chemistry · 1998 · 448 citations · Full text
Medicine, Cell Biology, Pharmacology +17